company background image
300584 logo

Nanjing Hicin Pharmaceutical SZSE:300584 Stock Report

Last Price

CN¥15.74

Market Cap

CN¥1.9b

7D

0.6%

1Y

-30.4%

Updated

12 Jul, 2024

Data

Company Financials

Nanjing Hicin Pharmaceutical Co., Ltd.

SZSE:300584 Stock Report

Market Cap: CN¥1.9b

300584 Stock Overview

Engages in the research, development, manufacture, marketing, and sale of pharmaceuticals, pharmaceutical preparations, and synthetic chemicals in China.

300584 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance4/6
Financial Health3/6
Dividends0/6

Nanjing Hicin Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Nanjing Hicin Pharmaceutical
Historical stock prices
Current Share PriceCN¥15.74
52 Week HighCN¥33.00
52 Week LowCN¥12.68
Beta0.11
11 Month Change-1.99%
3 Month Change-6.09%
1 Year Change-30.45%
33 Year Change-20.55%
5 Year Change-44.56%
Change since IPO47.56%

Recent News & Updates

We Think Nanjing Hicin Pharmaceutical's (SZSE:300584) Profit Is Only A Baseline For What They Can Achieve

May 01
We Think Nanjing Hicin Pharmaceutical's (SZSE:300584) Profit Is Only A Baseline For What They Can Achieve

Recent updates

We Think Nanjing Hicin Pharmaceutical's (SZSE:300584) Profit Is Only A Baseline For What They Can Achieve

May 01
We Think Nanjing Hicin Pharmaceutical's (SZSE:300584) Profit Is Only A Baseline For What They Can Achieve

Nanjing Hicin Pharmaceutical Co., Ltd.'s (SZSE:300584) 29% Price Boost Is Out Of Tune With Revenues

Mar 08
Nanjing Hicin Pharmaceutical Co., Ltd.'s (SZSE:300584) 29% Price Boost Is Out Of Tune With Revenues

Shareholder Returns

300584CN PharmaceuticalsCN Market
7D0.6%2.1%1.6%
1Y-30.4%-16.4%-18.4%

Return vs Industry: 300584 underperformed the CN Pharmaceuticals industry which returned -16.4% over the past year.

Return vs Market: 300584 underperformed the CN Market which returned -18.4% over the past year.

Price Volatility

Is 300584's price volatile compared to industry and market?
300584 volatility
300584 Average Weekly Movement6.8%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.0%
10% least volatile stocks in CN Market4.3%

Stable Share Price: 300584 has not had significant price volatility in the past 3 months.

Volatility Over Time: 300584's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003553Yuping Caowww.hicin.cn/page1/index1

Nanjing Hicin Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals, pharmaceutical preparations, and synthetic chemicals in China. It offers antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for cardio-cerebral system, and immuno-modulate agents. The company also provides technical transferring services.

Nanjing Hicin Pharmaceutical Co., Ltd. Fundamentals Summary

How do Nanjing Hicin Pharmaceutical's earnings and revenue compare to its market cap?
300584 fundamental statistics
Market capCN¥1.90b
Earnings (TTM)CN¥37.46m
Revenue (TTM)CN¥505.19m

50.4x

P/E Ratio

3.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300584 income statement (TTM)
RevenueCN¥505.19m
Cost of RevenueCN¥99.15m
Gross ProfitCN¥406.04m
Other ExpensesCN¥368.58m
EarningsCN¥37.46m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 23, 2024

Earnings per share (EPS)0.31
Gross Margin80.37%
Net Profit Margin7.41%
Debt/Equity Ratio27.0%

How did 300584 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

16%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.